Navigation Links
Cleveland Clinic research: Most statin-intolerant patients can eventually tolerate statins
Date:9/9/2013

Monday, September 9, 2013, Cleveland: Most patients who report statin intolerance, including muscle aches and other side effects from the cholesterol-lowering drugs, can actually tolerate drugs from this class on subsequent trials, according to research from Cleveland Clinic recently released online and forthcoming in the September issue of the American Heart Journal. The study is the largest ever to examine the effects of re-challenging statin-intolerant patients.

Statins are among the most prescribed drugs in the world and are a first-line, highly effective therapy for patients with high cholesterol, which is a major risk factor in the development of cardiovascular disease. Statins have been shown to reduce cholesterol levels by as much as 20 to 40 percent at the lowest dose level. However, in clinical trials, about 5 to 10 percent of patients have been reported as suffering from statin-related side effects like muscle pain and liver enzyme abnormalities, making them statin intolerant. In observational studies which often incorporate patients not typically selected for clinical trials, including older patients, more women, and those with comorbidities the rate of statin intolerance is as high as 20 percent.

In these patients, physicians often try intermittent dosing of statins, instructing patients to take the medication every other day, for instance, instead of daily, to reduce side effects.

Researchers, led by Leslie Cho, M.D., Section Head of Preventative Cardiology and Rehabilitation in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic, analyzed the electronic medical records of 1,605 patients who were referred to Cleveland Clinic for statin intolerance between January 1995 and March 2010.

Dr. Cho and her colleagues found that 72.5 percent of patients who were previously reported to be intolerant to two or more statins were able to take drugs from the class on subsequent trials when they were overseen in Cleveland Clinic's preventative cardiology clinic and had their statin regimen carefully restarted. Further, 63.2 percent of previously statin-intolerant patients were able to tolerate a daily statin regimen, with only 9.3 percent going on intermittent statin therapy. While those patients who remained on a daily dose of statin saw their cholesterol lowered to a greater extent than those on intermittent statin dosing, Dr. Cho and her colleagues found that the intermittent group did benefit significantly from the statin therapy.

"Our study shows that patients who have experienced statin intolerance should, under the close care of their physician, continue to try other drugs in this class because there is a very good chance that they will eventually be able to tolerate long-term use of a statin and benefit from its cholesterol-lowering effects," said Dr, Cho. "Even if patients cannot tolerate a daily dose of a statin, it's possible to see a significant reduction in cholesterol levels from taking the drug less often, even as infrequently as once a week."

Still, Dr. Cho points out that, given how widely statins are prescribed, it's important to note that almost 30 percent of the patients in the study remained statin intolerant and required alternative therapies to treat their high cholesterol.


'/>"/>

Contact: Wyatt DuBois
duboisw@ccf.org
216-445-9946
Cleveland Clinic
Source:Eurekalert

Related medicine news :

1. Cleveland Clinic research finds no benefit over placebo in ASSURE trial
2. Cleveland Clinic research finds blood pressure drug tends to slow coronary disease
3. Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancer
4. CE Lectures on the Dental Treatment of Snoring and Sleep Apnea Include Rochester, Cleveland and Ft. Lauderdale, as Sleep Seminar Destinations
5. Cleveland Indians vs. Detroit Tigers Tickets: Cheap Concert Tickets Slashes Prices on All Indians vs. Tigers Tickets for August 5th - August 8th Series Progressive Field
6. National Transitions of Care Coalition to Host Regional Summit in Cleveland
7. Maroon 5 & Kelly Clarkson Ticket Prices Slashed for Concerts in Long Island, Holmdel, Cincinnati, Pittsburgh, Camden/Philly, Boston/Mansfield, Chicago, Cleveland & Detroi
8. Explorys Proud to Sponsor Cleveland GiveCamp
9. NEONI Participates in Healthcare Career Event at Cleveland Convention Center Grand Opening
10. Cleveland Clinic Laboratories to provide testing and diagnostic services to ACL Laboratories
11. Book of Mormon Tickets: Prices Slashed on Book of Mormon Tickets in New York, Chicago, Cleveland, Buffalo, Washington DC, Minneapolis, Houston and San Antonio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2019)... ... , ... Trees can be overweight too! Giroud Tree and Lawn ... is a great time to clean things up on the property! , Health and ... during windy or icy storms. The crown of the tree should be pruned to ...
(Date:1/13/2019)... ... 2019 , ... New Vitae Wellness and Recovery is proud ... community, providing a variety of residential behavioral health and outpatient services. , “We ... and owner Adam Devlin. “We are continuing to build recovery communities and ...
(Date:1/11/2019)... ... January 11, 2019 , ... In Partnership with the Smiles for Everyone ... individuals at its Burleson, TX office on February 9. , Dental services ... and extractions . For more information, please visit the Monarch Dental ...
(Date:1/11/2019)... (PRWEB) , ... January 11, 2019 , ... ... treatment of endometriosis to remove inflammatory endometriosis tissue, relieve pain, and help restore ... the uterus.  In more common cases, tissue typically grows on the ovaries, fallopian ...
(Date:1/10/2019)... ... January 10, 2019 , ... The Karis Group, an Austin, Texas based company, ... Chief Executive Officer effective immediately. Mr. Jiwa succeeds the past Chief Executive Officer, ... The transition was announced as part of an orderly succession plan and transition ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... ... January 10, 2019 , ... Mindray, a leading developer of ... platform, providing a modular, state-of-the-art family of anesthesia solutions. The new series ... unwavering commitment to perioperative care. , “The recently launched Advantage platform further ...
(Date:1/8/2019)... ... January 08, 2019 , ... Mounting evidence in ... for their residents. Now the findings of a new survey seem to erase ... the International Council on Active Aging® (ICAA), the 2018 Active-Aging Industry Trends ...
(Date:1/7/2019)... FRANCISCO (PRWEB) , ... January 07, 2019 , ... ... obstetrics, announced today that Philips, the leading international health technology company, has taken ... financing. Additional investors include StartUp Health and NueCura Partners. , Babyscripts has spent ...
Breaking Medicine Technology: